Type I interferons in infectious disease

Role of the microbiota in immunity and inflammation.

Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385

The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets

Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,871

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

Ge, D., Fellay, J., Thompson, A. J. V., Simon, J. S., Shianna, K. V., Urban, T. J., Heinzen, E. L., Qiu, P., Bertelsen, A. H., Muir, A. J., et al. (2009) · Nature · doi:10.1038/nature08309 · Cited by 3,533

Regulation of type I interferon responses

Ivashkiv, L. B., & Donlin, L. T. (2013) · Nature reviews. Immunology · doi:10.1038/nri3581 · Cited by 3,442

Functional Role of Type I and Type II Interferons in Antiviral Defense

Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

Thomas, D. L., Thio, C. L., Martin, M. P., Qi, Y., Ge, D., Ó’hUigín, C., Kidd, J. R., Kídd, K. K., Khakoo, S. I., Alexander, G., et al. (2009) · Nature · doi:10.1038/nature08463 · Cited by 2,147

Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C

Tanaka, Y., Nishida, N., Sugiyama, M., Kurosaki, M., Matsuura, K., Sakamoto, N., Nakagawa, M., Korenaga, M., Hino, K., Hige, S., et al. (2009) · Nature Genetics · doi:10.1038/ng.449 · Cited by 2,141

An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis

Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., et al. (2010) · Nature · doi:10.1038/nature09247 · Cited by 1,898

Interferons, interferon‐like cytokines, and their receptors

Pestka, S., Krause, C. D., & Walter, M. R. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00204.x · Cited by 1,845

IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy

Study, F. T. H. C., Suppiah, V., Moldovan, M. V., Ahlenstiel, G., Berg, T., Weltman, M., Abate, M. L., Bassendine, M. F., Spengler, U., Dore, G. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.447 · Cited by 1,829

Squalene-epoxidase-catalyzed 24(S),25-epoxycholesterol synthesis promotes trained-immunity-mediated antitumor activity

Liu, Y., Wang, Z., Jin, H., Cui, L., Huo, B., Xie, C., Li, J., Ding, H., Zhang, H., Xiong, W., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114094 · Cited by 23

A hybrid method for discovering interferon-gamma inducing peptides in human and mouse

Dhall, A., Patiyal, S., & Raghava, G. P. S. (2024) · Scientific Reports · doi:10.1038/s41598-024-77957-8 · Cited by 23

Vagal TRPV1 + sensory neurons protect against influenza virus infection by regulating lung myeloid cell dynamics

Almanzar, N., Yang, D., Xia, J., Udit, S., Joshi, P. R., Adhikari, S., Hoagland, D. A., Yeung, S. T., Khairallah, C. F., Huerta, T. S., et al. (2025) · Science Immunology · doi:10.1126/sciimmunol.ads6243 · Cited by 27

Immune- and Nonimmune-Compartment-Specific Interferon Responses Are Critical Determinants of Herpes Simplex Virus-Induced Generalized Infections and Acute Liver Failure

Parker, Z. M., Pasieka, T. J., Parker, G. A., & Leib, D. A. (2016) · Journal of Virology · doi:10.1128/jvi.01473-16 · Cited by 23

Sequence analysis and characterization of type I interferon and type II interferon from the critically endangered sturgeon species, A. dabryanus and A. sinensis

Xu, Q., Luo, K., Zhang, S., Gao, W., Zhang, W., & Wei, Q. (2018) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2018.10.038 · Cited by 23

MxA suppresses TAK1-IKKα/β-NF-κB mediated inflammatory cytokine production to facilitate Mycobacterium tuberculosis infection

Zhou, X., Zhang, L., Lie, L., Zhang, Z., Zhu, B., Yang, J., Gao, Y., Li, P., Huang, Y., Xu, H., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.05.030 · Cited by 23

Structural insights into the distinctive RNA recognition and therapeutic potentials of RIG‐I‐like receptors

Batool, M., Kim, M. S., & Choi, S. (2021) · Medicinal Research Reviews · doi:10.1002/med.21845 · Cited by 23

Tupaia GBP1 Interacts with STING to Initiate Autophagy and Restrict Herpes Simplex Virus Type 1 Infection

Gu, T., Yu, D., Xu, L., Yao, Y., & Yao, Y. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100325 · Cited by 23

Beyond the List: Bioagent-Agnostic Signatures Could Enable a More Flexible and Resilient Biodefense Posture Than an Approach Based on Priority Agent Lists Alone

Leiser, O. P., Hobbs, E. C., Sims, A. M., Korch, G. W., & Taylor, K. (2021) · Pathogens · doi:10.3390/pathogens10111497 · Cited by 23

Autophagy and antiviral defense

Ke, P. (2021) · IUBMB Life · doi:10.1002/iub.2582 · Cited by 23

Herpes simplex virus interference with immunity: Focus on dendritic cells

Farías, M. A., Duarte, L. F., Tognarelli, E. I., & González, P. A. (2021) · Virulence · doi:10.1080/21505594.2021.1980990 · Cited by 23

Metabolic Sex Dimorphism of the Brain at the Gene, Cell, and Tissue Level

Lee, J. W., Profant, M. R., & Wang, C. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2100853 · Cited by 25

Simultaneous capture of ISG15 conjugating and deconjugating enzymes using a semi-synthetic ISG15-Dha probe

Li, C., Wang, T., Liang, L., Chu, G., Zhang, J., He, W. J., Liu, L., & Li, J. (2023) · Science China Chemistry · doi:10.1007/s11426-022-1455-x · Cited by 23

For Better or Worse: Cytosolic DNA Sensing during Intracellular Bacterial Infection Induces Potent Innate Immune Responses

Patrick, K. L., Bell, S. L., & Watson, R. O. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.04.030 · Cited by 24

Protective Immunity Induced by DNA Vaccination against Ranavirus Infection in Chinese Giant Salamander Andrias davidianus

Chen, Z., Li, T., Gao, X., Wang, C.-F., & Zhang, Q.-Y. (2018) · Viruses · doi:10.3390/v10020052 · Cited by 23

Exacerbated Apoptosis of Cells Infected with Infectious Bursal Disease Virus upon Exposure to Interferon Alpha

Cubas-Gaona, L. L., Díaz-Beneitez, E., Ciscar, M., Rodrígúez, J. F., & Rodrı́guez, D. (2018) · Journal of Virology · doi:10.1128/jvi.00364-18 · Cited by 23

A compartmentalized type I interferon response in the gut during chronic HIV-1 infection is associated with immunopathogenesis

Dillon, S. M., Guo, K., Austin, G. L., Gianella, S., Engen, P. A., Mutlu, E., Losurdo, J., Swanson, G. R., Chakradeo, P. S., Keshavarzian, A., et al. (2018) · AIDS · doi:10.1097/qad.0000000000001863 · Cited by 23

Molecular identification and antiviral function of the guanylate-binding protein (GBP) genes in the Chinese tree shrew (Tupaia belangeri chinesis)

Gu, T., Yu, D., Fan, Y., Wu, Y., Yao, Y., Xu, L., & Yao, Y. (2019) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2019.02.014 · Cited by 23

Hes1 attenuates type I IFN responses via VEGF-C and WDFY1

Ning, F., Li, X., Yu, L., Zhang, B., Zhao, Y., Liu, Y., Zhao, B., Shang, Y., & Hu, X. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20180861 · Cited by 23

Porcine Interferon Complex and Co-Evolution with Increasing Viral Pressure after Domestication

Jennings, J., & Sang, Y. (2019) · Viruses · doi:10.3390/v11060555 · Cited by 24

Cell-cycle-gated feedback control mediates desensitization to interferon stimulation

Mudla, A., Jiang, Y., Arimoto, K., Xu, B., Rajesh, A., Ryan, A. P., Wang, W., Daugherty, M. D., Zhang, D., & Hao, N. (2020) · eLife · doi:10.7554/elife.58825 · Cited by 25

Intranasal Immunization with the Influenza A Virus Encoding Truncated NS1 Protein Protects Mice from Heterologous Challenge by Restraining the Inflammatory Response in the Lungs

Vasilyev, K., Shurygina, A.-P. S., Sergeeva, M. V., Stukova, M., & Egorov, A. (2021) · Microorganisms · doi:10.3390/microorganisms9040690 · Cited by 24

Chronic SARS-CoV-2, a Cause of Post-acute COVID-19 Sequelae (Long-COVID)?

O’Donnell, J. S., & Chappell, K. J. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.724654 · Cited by 24

IFNs in host defence and parasite immune evasion during Toxoplasma gondii infections

Lüder, C. G. K. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1356216 · Cited by 22

Pathogenic Effects of IFIT2 and Interferon-β during Fatal Systemic Candida albicans Infection

Stawowczyk, M., Naseem, S., Montoya, V., Baker, D. P., Konopka, J. B., & Reich, N. C. (2018) · mBio · doi:10.1128/mbio.00365-18 · Cited by 24

Phytochemical Profiles and their Anti-inflammatory Responses Against Influenza from Traditional Chinese Medicine or Herbs

Ti, H. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520666200807134921 · Cited by 22

High Expression of IL-36γ in Influenza Patients Regulates Interferon Signaling Pathway and Causes Programmed Cell Death During Influenza Virus Infection

Liu, S., Li, H. J., Wang, Y., Li, H., Du, S., Zou, X., Zhang, X., & Cao, B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.552606 · Cited by 22

Deletion of immune evasion genes provides an effective vaccine design for tumor-associated herpesviruses

Brar, G., Farhat, N. A., Sukhina, A., Lam, A. K., Kim, Y., Hsu, T., Tong, L. M., Lin, W., Ware, C. F., Blackman, M. A., et al. (2020) · npj Vaccines · doi:10.1038/s41541-020-00251-x · Cited by 22

ISG15 protects human Tregs from interferon alpha‐induced contraction in a cell‐intrinsic fashion

Pacella, I., Spinelli, F. R., Severa, M., Timperi, E., Tucci, G., Zagaglioni, M., Ceccarelli, F., Rizzo, F., Coccia, E. M., Patel, R. S., et al. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1221 · Cited by 22

Aging‐related cell type‐specific pathophysiologic immune responses that exacerbate disease severity in aged COVID‐19 patients

Hou, Y., Zhou, Y., Gack, M. U., Luo, Y., Jehi, L., Chan, T. A.-T., Yu, H., Eng, C., Pieper, A. A., & Cheng, F. (2022) · Aging Cell · doi:10.1111/acel.13544 · Cited by 22

Deciphering Respiratory-Virus-Associated Interferon Signaling in COPD Airway Epithelium

Parke, H. G., Linden, D. A., Weldon, S., Kidney, J. C., & Taggart, C. C. (2022) · Medicina · doi:10.3390/medicina58010121 · Cited by 22

Monocyte and Macrophage Lipid Accumulation Results in Down-Regulated Type-I Interferon Responses

Willemsen, L., Chen, H., van Roomen, C. P. A. A., Griffith, G. R., Siebeler, R., Neele, A. E., Kroon, J., Hoeksema, M. A., & de Winther, M. P. J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.829877 · Cited by 23

Evolving Strategies to Eliminate the CD4 T Cells HIV Viral Reservoir via CAR T Cell Immunotherapy

York, J., Gowrishankar, K., Micklethwaite, K. P., Palmer, S., Cunningham, A. L., & Nasr, N. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.873701 · Cited by 22

Expedient Synthesis of Ubiquitin‐like Protein ISG15 Tools through Chemo‐Enzymatic Ligation Catalyzed by a Viral Protease Lbpro

Wang, T., Li, C., Wang, M., Zhang, J., Zheng, Q., Liang, L., Chu, G., Tian, X., Deng, H., He, W., et al. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202206205 · Cited by 22

Emerging Effects of IL-33 on COVID-19

Gao, Y., Cai, L., Li, L., Zhang, Y., Li, J., Luo, C., Wang, Y., & Tao, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113656 · Cited by 23

The role of STING signaling in central nervous system infection and neuroinflammatory disease

Fritsch, L. E., Kelly, C., & Pickrell, A. M. (2023) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1597 · Cited by 23

The value of Interferon β in multiple sclerosis and novel opportunities for its anti-viral activity: a narrative literature review

Bellucci, G., Albanese, A., Rizzi, C., Rinaldi, V., Salvetti, M., & Ristori, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1161849 · Cited by 23

Interferon stimulated immune profile changes in a humanized mouse model of HBV infection

Wang, Y., Guo, L., Shi, J., Li, J., Wen, Y., Gu, G., Cui, J., Feng, C., Jiang, M., Fan, Q., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43078-5 · Cited by 22

Human Metapneumovirus-Induced Host microRNA Expression Impairs the Interferon Response in Macrophages and Epithelial Cells

Martínez-Espinoza, I., Bungwon, A. D., & Guerrero-Plata, A. (2023) · Viruses · doi:10.3390/v15112272 · Cited by 22

Beyond autophagy: New roles for ULK1 in immune signaling and interferon responses

Saleiro, D., Kościuczuk, E. M., & Platanias, L. C. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.03.008 · Cited by 24

Attenuation of interferon regulatory factor 7 activity in local infectious sites of trachea and lung for preventing the development of acute lung injury caused by influenza A virus

Yang, L., Tu, L., Zhao, P., Wang, Y., Wang, S., Lu, W., Wang, Y., Li, X., Yu, Y., Hua, S., et al. (2019) · Immunology · doi:10.1111/imm.13045 · Cited by 22

Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection

Coya, J. M., Matteis, L. D., Giraud-Gatineau, A., Biton, A., Serrano‐Sevilla, I., Danckaert, A., Dillies, M., Gicquel, B., de la Fuente, J. M., & Tailleux, L. (2019) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0439-x · Cited by 22

IFN- β signalling regulates RAW 264.7 macrophage activation, cytokine production, and killing activity

Karimi, Y., Giles, E. C., Vahedi, F., Chew, M. V., Nham, T., Loukov, D., Lee, A. J., Bowdish, D. M. E., & Ashkar, A. A. (2019) · Innate Immunity · doi:10.1177/1753425919878839 · Cited by 22

Interferon Type I Regulates Inflammasome Activation and High Mobility Group Box 1 Translocation in Hepatocytes During Ehrlichia -Induced Acute Liver Injury

Kader, M., Andaloussi, A. E., Vorhaour, J., Tamama, K., Nieto, N., Scott, M. J., & Ismail, N. (2020) · Hepatology Communications · doi:10.1002/hep4.1608 · Cited by 22

SOCS-1 inhibition of type I interferon restrains Staphylococcus aureus skin host defense

Klopfenstein, N., Brandt, S. L., Castellanos, S., Gunzer, M., Blackman, A., & Serezani, C. H. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009387 · Cited by 23

IFN-λ Regulates Neutrophil Biology to Suppress Inflammation in Herpes Simplex Virus-1–Induced Corneal Immunopathology

Antony, F., Pundkar, C. Y., Sandey, M., Jaiswal, A. K., Mishra, A., Kumar, A., Channappanavar, R., & Suryawanshi, A. S. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2000979 · Cited by 22

Mutations in RNU7-1 Weaken Secondary RNA Structure, Induce MCP-1 and CXCL10 in CSF, and Result in Aicardi-Goutières Syndrome with Severe End-Organ Involvement

Naesens, L., Nemegeer, J., Roelens, F., Vallaeys, L., Meuwissen, M. E. C., Janssens, K., Verloo, P., Ogunjimi, B., Hemelsoet, D., (UD-PrOZA), P. F. U. R. D., et al. (2022) · Journal of Clinical Immunology · doi:10.1007/s10875-022-01209-5 · Cited by 22

The effects of SARS-CoV-2 infection on modulating innate immunity and strategies of combating inflammatory response for COVID-19 therapy

Wang, Y., Wu, M., Li, Y., Yuen, H. H., & He, M. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00811-4 · Cited by 22

Type 1 interferon licenses naïve CD8 T cells to mediate anti-viral cytotoxicity

Urban, S. L., Berg, L. J., & Welsh, R. M. (2016) · Virology · doi:10.1016/j.virol.2016.03.005 · Cited by 22

Crosstalk between type I and II interferons in regulation of myeloid cell responses during bacterial infection

Crisler, W. J., & Lenz, L. L. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.05.014 · Cited by 23

DUSP4 modulates RIG-I- and STING-mediated IRF3-type I IFN response

Jiao, H., James, S. J., Png, C. W., Cui, C., Li, H., Li, L., Chia, W. N., Min, N., Li, W., Claser, C., et al. (2024) · Cell Death and Differentiation · doi:10.1038/s41418-024-01269-7 · Cited by 21

Type 2 conventional dendritic cell functional heterogeneity: ontogenically committed or environmentally plastic?

León, B. (2025) · Trends in Immunology · doi:10.1016/j.it.2024.12.005 · Cited by 21

Type I interferon autoantibody footprints reveal neutralizing mechanisms and allow inhibitory decoy design

Groen, K., Kuratli, R., Enkelmann, J., Fernbach, S., Wendel‐Garcia, P. D., Staiger, W. I., Lejeune, M., Sauras-Colón, E., Roche‐Campo, F., Filippidis, P., et al. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20242039 · Cited by 22

Effect of Vipera ammodytes ammodytes Snake Venom on the Human Cytokine Network

Boda, F., Bánfai, K., Garai, K., Curticăpean, A., Berța, L., Sipos, E., & Kvell, K. (2018) · Toxins · doi:10.3390/toxins10070259 · Cited by 21

Decreased Type I Interferon Production by Plasmacytoid Dendritic Cells Contributes to Severe Dengue

Upasani, V., Scagnolari, C., Frasca, F., Smith, N., Bondet, V., Vanderlinden, A., Lay, S., Auerswald, H., Heng, S., Laurent, D., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.605087 · Cited by 23

Antiviral activities of sea perch type I and type II IFNs against RGNNV and their different roles in antigen presentation

Lu, X., Zeng, J., Jia, K., & Yi, M. (2020) · Aquaculture · doi:10.1016/j.aquaculture.2020.736314 · Cited by 21

Constitutive and latent immune mechanisms exert ‘silent’ control of virus infections in the central nervous system

Paludan, S. R., & Mogensen, T. H. (2021) · Current Opinion in Immunology · doi:10.1016/j.coi.2021.05.004 · Cited by 22

The novel therapeutic target and inhibitory effects of PF-429242 against Zika virus infection

Raini, S. K., Takamatsu, Y., Dumre, S. P., Urata, S., Mizukami, S., Moi, M. L., Hayasaka, D., Inoue, S., Morita, K., & Tun, M. M. N. (2021) · Antiviral Research · doi:10.1016/j.antiviral.2021.105121 · Cited by 21

Oral Administration of Lactococcus lactis Producing Interferon Type II, Enhances the Immune Response Against Bacterial Pathogens in Rainbow Trout

Santibáñez, Á., Paine‐Cabrera, D., Parra, M., Muñoz, C., Valdés, N., Zapata, C., Vargas, R. A., González, A., & Tello, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.696803 · Cited by 21

mRNA-based therapies: Preclinical and clinical applications

Qureischi, M., Mohr, J., Arellano-Viera, E., Knudsen, S. E., Vohidov, F., & Garitano-Trojaola, A. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.04.007 · Cited by 21

The mitochondrial gene-CMPK2 functions as a rheostat for macrophage homeostasis

Arumugam, P., Chauhan, M., Rajeev, T., Chakraborty, R., Bisht, K., Madan, M., Shankaran, D., Ramalingam, S., Gandotra, S., & Rao, V. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.935710 · Cited by 22

Lactobacillus salivarius HHuMin-U Activates Innate Immune Defense against Norovirus Infection through TBK1-IRF3 and NF-κB Signaling Pathways

Kim, D. H., Jeong, M., Kim, J. H., Son, J. E., Lee, J. J. Y., Park, S.-J., Lee, J., Kim, M., Oh, J., Park, M. S., et al. (2022) · Research · doi:10.34133/research.0007 · Cited by 21

USP18 is an essential regulator of muscle cell differentiation and maturation

Olie, C. S., Pinto-Fernández, A., Damianou, A., Vendrell, I., Mei, H., den Hamer, B., van der Wal, E., de Greef, J. C., Aronica, E., Raz, V., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05725-z · Cited by 21

Mesenchymal Stromal Cells Increase the Natural Killer Resistance of Circulating Tumor Cells via Intercellular Signaling of cGAS‐STING‐IFNβ‐HLA

Ye, Y., Qin, G., Yang, H., Hao, J., Zeng, Q., Zheng, D., Ye, S., Zhang, Z., Liu, T., Luo, K. Q., et al. (2024) · Advanced Science · doi:10.1002/advs.202400888 · Cited by 22

Exercise activates interferon response of the liver via Gpld1 to enhance antiviral innate immunity

Ren, T., He, J., Zhang, T., Niu, A.-X., Yuan, Y., Zuo, Y., Miao, Y., Hongguang, Z., Zang, L., Qiao, C., et al. (2024) · Science Advances · doi:10.1126/sciadv.adk5011 · Cited by 23

Alphaviruses suppress host immunity by preventing myeloid cell replication and antagonizing innate immune responses

Trobaugh, D. W., & Klimstra, W. B. (2017) · Current Opinion in Virology · doi:10.1016/j.coviro.2017.02.004 · Cited by 21

Innate Immune Basis for Rift Valley Fever Susceptibility in Mouse Models

Lathan, R., Simon‐Chazottes, D., Jouvion, G., Godon, O., Malissen, M., Flamand, M., Bruhns, P., & Panthier, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-07543-8 · Cited by 21

Type I Interferon Induced by Streptococcus suis Serotype 2 is Strain-Dependent and May Be Beneficial for Host Survival

Auger, J.-P., Santinón, A. X., Roy, D., Mossman, K. L., Xu, J., Segura, M., & Gottschalk, M. G. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01039 · Cited by 21

Fc gamma receptor IIa suppresses type I and III interferon production by human myeloid immune cells

Newling, M., Hoepel, W., Vogelpoel, L. T. C., Heineke, M. H., van Burgsteden, J. A., Taanman-Kueter, E. W., Eggink, D., Kuijpers, T. W., Beaumont, T., van Egmond, M., et al. (2018) · European Journal of Immunology · doi:10.1002/eji.201847615 · Cited by 21

Combating viral contaminants in CHO cells by engineering innate immunity

Chiang, A. W. T., Li, S., Kellman, B. P., Chattopadhyay, G., Zhang, Y., Kuo, C., Gutierrez, J. M., Ghazi, F., Schmeisser, H., Ménard, P., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-45126-x · Cited by 23

Macrophage migration inhibitory factor enhances influenza-associated mortality in mice

Smith, C. A., Tyrrell, D. J., Kulkarni, U., Wood, S. C., Leng, L., Zemans, R. L., Bucala, R., & Goldstein, D. R. (2019) · JCI Insight · doi:10.1172/jci.insight.128034 · Cited by 21

Virus infection is controlled by hematopoietic and stromal cell sensing of murine cytomegalovirus through STING

Piersma, S. J., Poursine‐Laurent, J., Yang, L., Barber, G. N., Parikh, B. A., & Yokoyama, W. M. (2020) · eLife · doi:10.7554/elife.56882 · Cited by 22

Requisite Omega-3 HUFA Biomarker Thresholds for Preventing Murine Lupus Flaring

Wierenga, K. A., Strakovsky, R. S., Benninghoff, A. D., Rajasinghe, L. D., Lock, A. L., Harkema, J. R., & Pestka, J. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01796 · Cited by 21

Type I interferon mediated induction of somatostatin leads to suppression of ghrelin and appetite thereby promoting viral immunity in mice

Stutte, S., Ruf, J., Kugler, I., Ishikawa-Ankerhold, H. C., Parzefall, A., Marconi, P., Maeda, T., Kaisho, T., Krug, A., Popper, B., et al. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.04.018 · Cited by 22

Recent Insights Into the Molecular Mechanism of Toll-Like Receptor Response to Dengue Virus Infection

Kayesh, M. E. H., Kohara, M., & Tsukiyama–Kohara, K. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.744233 · Cited by 21

Constitutive IFNα Protein Production in Bats

Bondet, V., Baut, M. L., Poder, S. L., Lécu, A., Petit, T., Wedlarski, R., Duffy, D., & Roux, D. L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.735866 · Cited by 24

A Novel Non–Mammalian-Specific HERC7 Negatively Regulates IFN Response through Degrading RLR Signaling Factors

Li, Y., Gong, X.-Y., Qu, Z.-L., Zhao, X., Dan, C., Gui, J., & Zhang, Y.-B. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2100962 · Cited by 21

Toxoplasma gondii ROP18 I inhibits host innate immunity through cGAS‐STING signaling

Chen, M., Yao, L., Zhou, L., Yang, P., Zou, W., Xu, L., Li, S., & Peng, H. (2022) · The FASEB Journal · doi:10.1096/fj.202101347r · Cited by 21

SARS-CoV-2 infection causes intestinal cell damage: Role of interferon’s imbalance

Sousa, S. G., de Sousa, A. K., Pereira, C. M. C., Araújo, A. S. M. L., Magalhães, D. D. A., de Brito, T. V., & Barbosa, A. L. D. R. (2022) · Cytokine · doi:10.1016/j.cyto.2022.155826 · Cited by 25

CRIg+ macrophages deficiency enhanced inflammation damage in IBD due to gut extracellular vesicles containing microbial DNA

Nie, S., Zhang, Z., Ji, Y., Ding, Q., Gong, J., Xiao, F., Chen, L., Tian, D., Liu, M., & Luo, Z. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2379633 · Cited by 20

IRF3 regulates neuroinflammatory responses and the expression of genes associated with Alzheimer’s disease

Joshi, R., Brezáni, V., Mey, G. M., Guixé‐Muntet, S., Ortega‐Ribera, M., Zhuang, Y., Zivny, A., Werneburg, S., Gracia‐Sancho, J., & Szabó, G. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03203-7 · Cited by 22

The importance of type I interferon in orchestrating the cytotoxic T-cell response to cancer

Busselaar, J., Sijbranda, M., & Borst, J. G. (2024) · Immunology Letters · doi:10.1016/j.imlet.2024.106938 · Cited by 21

Preclinical testing of antiviral siRNA therapeutics delivered in lipid nanoparticles in animal models – a comprehensive review

Idres, Y. M., Idris, A., & Gao, W. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01815-x · Cited by 21

Prevention of tuberculosis in cynomolgus macaques by an attenuated Mycobacterium tuberculosis vaccine candidate

Singh, D. K., Ahmed, M., Akter, S., Shivanna, V., Bucşan, A. N., Mishra, A., Golden, N., Didier, P. J., Doyle‐Meyers, L. A., Hall-Ursone, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57090-4 · Cited by 20

The Type I Interferon Axis in Systemic Autoimmune Diseases: From Molecular Pathways to Targeted Therapy

Ishihara, R., Watanabe, R., Shiomi, M., Fujita, Y., Katsushima, M., Fukumoto, K., Yamada, S., & Hashimoto, M. (2025) · Biomolecules · doi:10.3390/biom15111586 · Cited by 20

Variation in the Early Host-Pathogen Interaction of Bovine Macrophages with Divergent Mycobacterium bovis Strains in the United Kingdom

Jensen, K., Gallagher, I. J., Johnston, N., Welsh, M., Skuce, R., Williams, J. L., & Glass, E. J. (2017) · Infection and Immunity · doi:10.1128/iai.00385-17 · Cited by 20

Characterization of host proteins interacting with the lymphocytic choriomeningitis virus L protein

Khamina, K., Lercher, A., Caldera, M., Schliehe, C., Vilagos, B., Sahin, M., Kosack, L., Bhattacharya, A., Májek, P., Stukalov, A., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006758 · Cited by 20

Overexpression of Chicken IRF7 Increased Viral Replication and Programmed Cell Death to the Avian Influenza Virus Infection Through TGF-Beta/FoxO Signaling Axis in DF-1

Kim, T. H., & Zhou, H. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00415 · Cited by 20

Are we fully exploiting type I Interferons in today's fight against COVID-19 pandemic?

Aricò, E., Bracci, L., Castiello, L., Gessani, S., & Belardelli, F. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.07.010 · Cited by 20

Single-cell transcriptomics reveal DHX9 in mature B cell as a dynamic network biomarker before lymph node metastasis in CRC

Liu, H., Zhong, J., Hu, J., Han, C., Li, R., Yao, X., Liu, S., Chen, P., Liu, R., & Ling, F. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.06.004 · Cited by 20

Chromatin remodeler ARID1A binds IRF3 to selectively induce antiviral interferon production in macrophages

Hu, Y., Wang, X., Song, J., Wu, J., Xu, J. M., Chai, Y., Ding, Y., Wang, B., Wang, C., Zhao, Y. B., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04032-9 · Cited by 20

Elevated Serum Levels of Progranulin and Soluble Vascular Cell Adhesion Molecule-1 in Patients with COVID-19

Yao, S., Luo, N., Liu, J., Zha, H., Ai, Y., Luo, J., Shi, S., & Wu, K. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s330356 · Cited by 20

DDX50 Is a Viral Restriction Factor That Enhances IRF3 Activation

Pallett, M. A., Lu, Y., & Smith, G. L. (2022) · Viruses · doi:10.3390/v14020316 · Cited by 20

Structural and Functional Analyses of Type I IFNa Shed Light Into Its Interaction With Multiple Receptors in Fish

Wang, Z., Xu, J., Feng, J., Wu, K., Chen, K., Jia, Z., Zhu, X., Huang, W., Zhao, X., Liu, Q., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.862764 · Cited by 20

Distinct Cellular Immune Responses to SARS-CoV-2 in Pregnant Women

Gomez‐Lopez, N., Romero, R. J., Li, T., Gershater, M., Leng, Y., Zou, C., Farías, M., Galaz, J., Miller, D., Tarca, A. L., et al. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2101123 · Cited by 20

The deciphering of the immune cells and marker signature in COVID‐19 pathogenesis: An update

Jasim, S. A., Mahdi, R. S., Bokov, D. O., Najm, M. A. A., Sobirova, G. N., Bafoeva, Z. O., Taifi, A., Alkadir, O. K. A., Mustafa, Y. F., Mirzaei, R., et al. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28000 · Cited by 21

A hnRNPA2B1 agonist effectively inhibits HBV and SARS-CoV-2 omicronin vivo

Zuo, D., Chen, Y., Cai, J., Yuan, H.-Y., Wu, J., Yin, Y., Xie, J., Lin, J., Luo, J., Feng, Y., et al. (2022) · Protein & Cell · doi:10.1093/procel/pwac027 · Cited by 20

Intensive care unit-acquired weakness: A review from molecular mechanisms to its impact in COVID-2019

González, A., Ábrigo, J., Achiardi, O. A., Simón, F., & Cabello‐Verrugio, C. (2022) · European Journal of Translational Myology · doi:10.4081/ejtm.2022.10511 · Cited by 22

Attenuation of IFN signaling due to m6A modification of the host epitranscriptome promotes EBV lytic reactivation

Bose, D., Lin, X., Gao, L., Wei, Z., Pei, Y., & Robertson, E. S. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00911-9 · Cited by 20

Interim analysis of a phase 1 randomized clinical trial on the safety and immunogenicity of the mRNA-1283 SARS-CoV-2 vaccine in adults

Yassini, P., Hutchens, M., Paila, Y. D., Schoch, L., Aunins, A., Siangphoe, U., & Paris, R. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2190690 · Cited by 21

Confounding roles for type I interferons during bacterial and viral pathogenesis

Carrero, J. A. (2013) · International Immunology · doi:10.1093/intimm/dxt050 · Cited by 58

Type I Interferons in Bacterial Infections: Taming of Myeloid Cells and Possible Implications for Autoimmunity

Eshleman, E. M., & Lenz, L. L. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00431 · Cited by 37

Disease-Promoting Effects of Type I Interferons in Viral, Bacterial, and Coinfections

Davidson, S., Maini, M. K., & Wack, A. (2015) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0227 · Cited by 201

Protective versus Pathogenic Type I Interferon Responses during Virus Infections

Jung, K. I., McKenna, S., Vijayamahantesh, V., He, Y., & Hahm, B. (2023) · Viruses · doi:10.3390/v15091916 · Cited by 25

Suppression of interleukin-17 by type I interferons: a contributing factor in virus-induced immunosuppression?

Tilg, H., Moschen, A. R., & Kaser, A. (2009) · European Cytokine Network · doi:10.1684/ecn.2009.0141 · Cited by 16